Vanda Pharmaceuticals Inc (STU:VM4) Stock News, Headlines & Updates
Vanda Pharmaceuticals Inc Stock News from GuruFocus
- 1
Jul 01, 2024
Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex
PRNewswire • 8:00am
Jun 20, 2024
Vanda Pharmaceuticals Board of Directors Determines that Recent Unsolicited Takeover Proposals Are Not in the Best Interests of the Company and its Shareholders
PRNewswire • 8:00pm
Jun 13, 2024
Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
PRNewswire • 10:00am
Jun 10, 2024
Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.
Business Wire • 8:00am
Jun 06, 2024
Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.
PRNewswire • 9:00am
May 30, 2024
Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference
PRNewswire • 5:00pm
Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY®
PRNewswire • 4:00pm
May 29, 2024
Vanda Pharmaceuticals Announces Presentations at SLEEP 2024
PRNewswire • 2:00pm
May 24, 2024
Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders
PRNewswire • 4:00pm
May 15, 2024
Vanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion Sickness
PRNewswire • 8:00am
May 10, 2024
Vanda Pharmaceuticals Reports Mixed Q1 2024 Results, Misses Revenue Estimates
GuruFocus Research • 1:24pm
May 09, 2024
Vanda Pharmaceuticals Inc (VNDA) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and Seizing Opportunities
GuruFocus Research • 1:38am
Q1 2024 Vanda Pharmaceuticals Inc Earnings Call Transcript
GuruFocus Research • 11:33pm
May 08, 2024
Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results
PRNewswire • 4:00pm
May 07, 2024
Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
PRNewswire • 11:00am
Apr 30, 2024
Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024
PRNewswire • 4:00pm
Apr 25, 2024
Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
Marketwired • 8:00am
Apr 23, 2024
Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation
PRNewswire • 7:00pm
Apr 17, 2024
Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan
PRNewswire • 10:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news